Max Robotics — Global Service Robot Directory + US Certification

About

Conor E. Steuer is a leading surgical oncologist whose research focuses on refining treatment paradigms for oropharyngeal squamous cell carcinoma (OPSCC), particularly through the lens of transoral robotic surgery (TORS). His work has fundamentally challenged traditional approaches to head and neck cancer care, demonstrating that omission of intentional primary site radiation after TORS can achieve excellent locoregional control—a finding from his 2021 study that has garnered 10 citations and reshaped de-escalation strategies. Steuer’s investigation into real-world outcomes, including a 2022 analysis of 90-day mortality across Commission on Cancer-accredited facilities (6 citations), provided critical evidence that TORS is associated with low postoperative mortality outside clinical trials, validating its broader adoption. His 2022 study on specimen-based resection margins (3 citations) further advanced surgical precision by clarifying the relationship between margin status and local control in HPV-mediated disease. By systematically evaluating surgical versus radiation approaches, Steuer has helped define evidence-based, de-intensified treatment pathways that reduce toxicity while preserving oncologic outcomes. His work is essential reading for clinicians and researchers seeking to optimize organ-preserving strategies in oropharyngeal cancer.